Ben Broster has joined fellow prop Cobus Visagie in signing a new Saracens contract. Just days after securing the future of Cobus Visagie, Saracens have tied prop Ben Broster to a new two-year deal.

Explore Corbus Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRBP. Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial ...

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall readout is in line with the Chinese data that drummed up excitement in the ...

Corbus Pharmaceuticals has a 12 month low of $6.54 and a 12 month high of $61.90. The stock’s fifty day moving average price is $9.98 and its 200-day moving average price is $20.82.

Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm ...